Advertisement

Technetium-99m-labeled perfusion tracers for the detection of myocardial viability

Chapter
  • 51 Downloads
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 226)

Abstract

Technetium-99m(Tc-99m)-labeled myocardial perfusion tracers offer several advantages over thallium-201 for the diagnosis and evaluation of coronary artery disease. However, because of the results of some early human studies, concerns were advanced about their usefulness and reliability for the detection of viable hibernating myocardium. The majority of the experimental data and the more recent clinical reports have greatly reduced these concerns, so that the use of Tc-99m-labeled myocardial perfusion tracers for the issue of viability detection should be probably considered a reasonable alternative to the other established methods. The largest experience has been collected about Tc-99m-sestamibi and will be thoroughly examined in the following sections. Promising data, which are briefly reported as well, are now becoming available about the other currently used Tc-99m-labeled perfusion tracer, Tc-99m-tetrofosmin.

Keywords

Myocardial Viability Chronic Coronary Artery Disease Perfusion Tracer Nitrate Administration Viability Detection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988;77:491–498.PubMedCrossRefGoogle Scholar
  2. 2.
    Leppo JA, Meerdink DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile and thallium. Circ Res 1989;65:632–639.PubMedCrossRefGoogle Scholar
  3. 3.
    Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990;82:1826–1838.PubMedCrossRefGoogle Scholar
  4. 4.
    Piwnica-Worms D, Chiu ML, Kronauge JF. Divergent kinetics of 201Tl and 99mTc-sestamibi in cultured chick ventricular myocites during ATP depletion. Circulation 1992;85:1531–1541.PubMedCrossRefGoogle Scholar
  5. 5.
    Beanlands RSB, Dawood F, Wen WH et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990;82:1802–18PubMedCrossRefGoogle Scholar
  6. 6.
    Canby RC, Silber S, Pohost GM. Relations of the myocardial imaging agents 99mTc-MIBI and 201Tl to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation 1990;81:289–296.PubMedCrossRefGoogle Scholar
  7. 7.
    Sinusas AJ, Trautman KA, Bergin JD et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation 1990;82:1424–1437.PubMedCrossRefGoogle Scholar
  8. 8.
    Freeman I, Grunwald AM, Hoory S, Bodenheimer MM. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med 1991;32:292–298.PubMedGoogle Scholar
  9. 9.
    Sansoy V, Glover DK, Watson DD et al. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation 1995;92:994–1004.PubMedCrossRefGoogle Scholar
  10. 10.
    Wackers F, Berman D, Maddahi J et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301–311.PubMedGoogle Scholar
  11. 11.
    Kiat H, Maddahi J, Roy LT et al. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989;117:1–11.PubMedCrossRefGoogle Scholar
  12. 12.
    Parodi O, Marcassa C, Casucci R et al. Accuracy and safety of Technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: a multicenter study. J Am Coll Cardiol 1991;18:1439–1444.PubMedCrossRefGoogle Scholar
  13. 13.
    Rocco TP, Dilsizian V, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest. II. Relation to clinical markers of potential viability. J Am Coll Cardiol 1989;14:1678–1684.PubMedCrossRefGoogle Scholar
  14. 14.
    Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992;33:505–511.PubMedGoogle Scholar
  15. 15.
    Cuocolo A, Maurea S, Pace L et al. Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy. Eur J Nucl Med 1993;20:1186–1192.PubMedCrossRefGoogle Scholar
  16. 16.
    Maurea S, Cuocolo A, Pace L et al. Rest-injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity of coronary artery stenosis. Eur J Nucl Med 1993;20:502–510.PubMedCrossRefGoogle Scholar
  17. 17.
    Dondi M, Tartagni F, Fallani F et al. A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography: possible implications for myocardial viability detection in infarcted patients. Eur J Nucl Med 1993;20:26–31.PubMedCrossRefGoogle Scholar
  18. 18.
    Dilsizian V, Arrighi JA, Diodati JG et al. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F] fluorodeoxyglucose. Circulation 1994;89:578–587.PubMedCrossRefGoogle Scholar
  19. 19.
    Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996;27:1592–1597.PubMedCrossRefGoogle Scholar
  20. 20.
    Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of the currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451–1460.PubMedCrossRefGoogle Scholar
  21. 21.
    Sciagrà R, Santoro GM, Bisi G, Pedenovi P, Fazzini PF, Pupi A. Rest-redistribution thallium-201 SPECT to detect myocardial viability. J Nucl Med 1998;39:384–390.PubMedGoogle Scholar
  22. 22.
    Lucignani G, Paolini G, Landoni C et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18-fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992;19:874–881.PubMedCrossRefGoogle Scholar
  23. 23.
    Altehoefer C, Kaiser HJ, Dörr R et al. Fluorine-18 deoxyglucose PET for the assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med 1992;19:334–342.PubMedCrossRefGoogle Scholar
  24. 24.
    Altehoefer C, von Dahl J, Biedermann M et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994;35:569–574.PubMedGoogle Scholar
  25. 25.
    Sawada SG, Allman KC, Muzik O et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994;23:92–98.PubMedCrossRefGoogle Scholar
  26. 26.
    Soufer R, Dey HM, Ng CK, Zaret BL. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 1995;75:1214–1219.PubMedCrossRefGoogle Scholar
  27. 27.
    Arrighi JA, Ng CK, Dey HM, Wackers FJT, Soufer R. Effect of left ventricular function on the assessment of myocardial viability by technetium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris or both. Am JCardiol 1997;80:1007–1013.CrossRefGoogle Scholar
  28. 28.
    Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992;33:1925–1930.PubMedGoogle Scholar
  29. 29.
    Marzullo P, Parodi O, Reisenhofer B et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166–172.PubMedCrossRefGoogle Scholar
  30. 30.
    Marzullo P, Sambuceti G, Parodi O et al. Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery. J Nucl Cardiol 1995;2:309–316.PubMedCrossRefGoogle Scholar
  31. 31.
    Maublant JC, Citron B, Lipiecki J et al. Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium. Am Heart J 1995;129:306–314.PubMedCrossRefGoogle Scholar
  32. 32.
    Udelson JE, Coleman PS, Metherall J et al. Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994;89:2552–2561.PubMedCrossRefGoogle Scholar
  33. 33.
    Dakik HA, Howell JF, Lawrie GM et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997;96:2892–2898.PubMedCrossRefGoogle Scholar
  34. 34.
    Maes AF, Borgers M, Flameng W et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow up. J Am Coll Cardiol 1997;29:62–68.PubMedCrossRefGoogle Scholar
  35. 35.
    Maurea S, Cuocolo A, Soricelli A et al. Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution. J Nucl Med 1995;36:1953–1960.PubMedGoogle Scholar
  36. 36.
    Worsley DF, Fung AY, Jue J, Burns RJ. Identification of viable myocardium with technetium-99m-MIBI infusion. J Nucl Med 1995;36:1037–1039.PubMedGoogle Scholar
  37. 37.
    González P, Massardo T, Muñoz A et al. Is the addition of ECG gating to technetium-99m sestamibi SPET of value in the assessment of myocardial viability? An evaluation based on two-dimensional echocardiography following revascularization. Eur J Nucl Med 1996;23:1315–1322.PubMedCrossRefGoogle Scholar
  38. 38.
    Levine MG, McGill CC, Ahlberg AW et al. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999;83:1–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol 1992;70:30B–42B.PubMedCrossRefGoogle Scholar
  40. 40.
    Heifant RH, Pine R, Meister SG, Feldman MS, Trout RG, Banka VS. Nitroglyserin to unmask reversible asynergy. Correlation with post coronary bypass ventriculography. Circulation 1974;50:108–133.CrossRefGoogle Scholar
  41. 41.
    Aoki M, Sakai K, Koyanagi S, Takeshita A, Nakamura M. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography. Am Heart J 1991;121:1361–1366.PubMedCrossRefGoogle Scholar
  42. 42.
    He Z-X, Darcourt J, Guigner A et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med 1993;34:1472–1477.PubMedGoogle Scholar
  43. 43.
    Bisi G, Sciagrà R, Santoro GM, Zerauschek F, Fazzini PF. Sublingual isosorbide dinitrate to improve Tc-99m-teboroxime perfusion defect reversibility. J Nucl Med 1994;35:1274–1278.PubMedGoogle Scholar
  44. 44.
    Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi P. Effects of nitroglycerin by Technetium-99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994;74:843–848.PubMedCrossRefGoogle Scholar
  45. 45.
    Bisi G, Sciagrà R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282–1289.PubMedCrossRefGoogle Scholar
  46. 46.
    Bisi G, Sciagrà R, Santoro GM, Rossi V, Fazzini PF. Techentium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995;36:1994–2000.PubMedGoogle Scholar
  47. 47.
    Maurea S, Cuocolo A, Soricelli A et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. JNucl Med 1995;36:1945–1952.Google Scholar
  48. 48.
    Li ST, Liu XJ, Lu ZL et al. Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization. J Nucl Cardiol 1996;3:457–463.PubMedCrossRefGoogle Scholar
  49. 49.
    Greco C, Tanzilli G, Ciavolella M et al. Nitroglycerin-induced changes in myocardial sestamibi uptake to detect tissue viability: radionuclide comparison before and after revascularization. Coronary Artery Disease 1996;7:877–884.PubMedCrossRefGoogle Scholar
  50. 50.
    Sciagrà R, Bisi G, Santoro GM, Agnolucci M, Zoccarato O, Fazzini PF. Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labeled sestamibi single photon emission computed tomography. J Nucl Cardiol 1996;3:221–230.PubMedCrossRefGoogle Scholar
  51. 51.
    Sciagrà R, Bisi G, Santoro GM et al. Comparison of baseline-nitrate technetium-99m-sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997;30:384–391.PubMedCrossRefGoogle Scholar
  52. 52.
    Schneider CA, Voth E, Gawlich S et al. Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: importance of infarct location adjusted thresholds. J Am Coll Cardiol 1998;32:648–654.PubMedCrossRefGoogle Scholar
  53. 53.
    Zaret BL, Rigo P, Wackers FJTh et al. Myocardial perfusion imaging with 99mTc-tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicentre trial. Circulation 1995;91:313–319.PubMedCrossRefGoogle Scholar
  54. 54.
    Platts EA, North TL, Picket RD, Kelley JD. Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocites and subcellular localization. J Nucl Cardiol 1995;2:317–326.PubMedCrossRefGoogle Scholar
  55. 55.
    Younes A, Songadele JA; Maublant J et al. Mechanism of uptake of technetium-tetrofosmin. II: uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 1995;2:327–333.PubMedCrossRefGoogle Scholar
  56. 56.
    Koplan BA, Beller GA, Ruiz M et al. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction. J Nucl Med 1996;37:1398–1402.PubMedGoogle Scholar
  57. 57.
    Matsunari I, Fujino S, Taki J et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995;36:1961–1967.PubMedGoogle Scholar
  58. 58.
    Matsunari I, Fujino S, Taki J et al. Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201. J Am Coll Cardiol 1997;29:1226–1233.PubMedCrossRefGoogle Scholar
  59. 59.
    Thorley PJ, Bloomer TN, Sheard KL et al. The use of GTN to improve the detection of ischaemic myocardium using 99mTc-tetrofosmin. Nucl Med Commun 1996;17:669–674.PubMedCrossRefGoogle Scholar
  60. 60.
    Derebek E, Kozan O, Durak H et al. Sublingual nitrate plus 99Tcm-tetrofosmin infusion in the detection of severely ischaemic but viable myocardium: a comparative study with stress, redistribution, reinjection and late redistribution 201Tl imaging. Nucl Med Commun 1996;17:864–871.PubMedCrossRefGoogle Scholar
  61. 61.
    Flotats A, Carriò I, Estorch M et al. Nitrate administration to enhance detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography. Eur J Nucl Med 1997;24:767–773.PubMedGoogle Scholar
  62. 62.
    Peix A, López A, Ponce F et al. Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration. J Nucl Cardiol 1998;5:469–476.PubMedCrossRefGoogle Scholar
  63. 63.
    Sciagrà R, Pupi A, Pellegri M, Santoro GM, Casolo GC, Sestini S. Prediction of global left ventricular (LV) ejection fraction (EF) improvement after coronary revascularization (rev) using Tc-99m-Sestamibi SPECT [abstract]. J Nucl Med 1999;40(5 Suppl):49P.Google Scholar
  64. 64.
    Sciagrà R, Pellegri M,. Santoro GM, Sestini F, Zerauschek F, Fazzini PF. Prognostic implications of viability detection with baseline-nitrate Tc-99m-Sestamibi SPECT in patients with LV dysfunction [abstract]. Eur J Nucl Med 1998;25:851.Google Scholar
  65. 65.
    Iskandrian AS, Acio E. Methodology of a novel myocardial viability protocol. J Nucl Cardiol 1998;5:206–209.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2000

Authors and Affiliations

There are no affiliations available

Personalised recommendations